Prestige Consumer Healthcare Inc.PBHEarnings & Financial Report
Prestige Consumer Healthcare Inc. is an American company that markets and distributes over-the-counter healthcare and household cleaning products. It was formed by the merger of Medtech Products, Inc., Prestige Brands International, and the Spic and Span Company in 1996. The company is headquartered in Tarrytown, New York and operates a manufacturing facility in Lynchburg, Virginia.
PBH Q3 2026 Key Financial Metrics
Revenue
$283.4M
Gross Profit
$157.4M
Operating Profit
$82.5M
Net Profit
$46.7M
Gross Margin
55.5%
Operating Margin
29.1%
Net Margin
16.5%
YoY Growth
-2.4%
EPS
$0.97
Financial Flow
Prestige Consumer Healthcare Inc. Q3 2026 Financial Summary
Prestige Consumer Healthcare Inc. reported revenue of $283.4M for Q3 2026, with a net profit of $46.7M (16.5% margin). Cost of goods sold was $126.1M, operating expenses totaled $74.9M.
Key Financial Metrics
| Total Revenue | $283.4M |
|---|---|
| Net Profit | $46.7M |
| Gross Margin | 55.5% |
| Operating Margin | 29.1% |
| Report Period | Q3 2026 |
Prestige Consumer Healthcare Inc. Annual Revenue by Year
Prestige Consumer Healthcare Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $1.1B).
| Year | Annual Revenue |
|---|---|
| 2025 | $1.1B |
| 2024 | $1.1B |
| 2023 | $1.1B |
| 2022 | $1.1B |
Income Statement
| Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $277.0M | $267.1M | $283.8M | $290.3M | $296.5M | $249.5M | $274.1M | $283.4M |
| YoY Growth | -3.1% | -4.4% | -0.9% | 2.7% | 7.0% | -6.6% | -3.4% | -2.4% |
Balance Sheet
| Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $3.32B | $3.31B | $3.32B | $3.33B | $3.40B | $3.43B | $3.44B | $3.49B |
| Liabilities | $1.66B | $1.63B | $1.59B | $1.54B | $1.57B | $1.58B | $1.62B | $1.67B |
| Equity | $1.66B | $1.68B | $1.73B | $1.79B | $1.83B | $1.86B | $1.82B | $1.83B |
Cash Flow
| Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $66.9M | $54.8M | $69.8M | $65.1M | $61.8M | $79.0M | $57.5M | $78.3M |